Annual report pursuant to Section 13 and 15(d)

Derivative Financial Instruments

Derivative Financial Instruments
12 Months Ended
Dec. 31, 2018
Investments, All Other Investments [Abstract]  
Derivative Financial Instruments



On May 18, 2018, as an inducement to enter into an Amended and Restated Loan Agreement, the Company issued, among other instruments, warrants to acquire 320,000 shares of common stock with an exercise price of $0.10 per share in Canadian dollars (see Note 7). The warrants are valued using the Black Scholes Option Pricing Model and the derivative is fair valued at the end of each reporting period. The Company valued the derivative liability at initial recognition as $30,012.


A summary of the activity of the derivative liabilities is shown below:


Balance, January 1, 2018   $  
Additions     30,012  
Fair value adjustments     7,001  
As at December 31, 2018   $ 37,013  


Derivative liability classified warrants in the years ended December 31, 2018 were valued using the Black Scholes Option Pricing Model with the range of assumptions outlined below. Expected life was determined based on historical exercise data of the Company.


    December 31, 2018  
Risk-free interest rate     2.48% - 2.88%  
Expected life     2.4 - 3.0 years  
Expected dividend rate     0 %
Expected volatility     202% - 293%